Matthew E Garth
CIK 1695300 · View on SEC EDGAR ↗
First SEC filing: Dec. 5, 2022 · Latest: Oct. 15, 2025
On this page
- Insider at Companies where this person is a reporting insider.
- Insider transactions Every share this person bought or sold, from Form 4 filings.
- Derivatives Options and other derivative holdings reported by this person.
- Initial holdings The stakes this person held when they first started reporting.
- Compensation Executive pay disclosed in company proxy statements.
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Oct. 10, 2025 | XRAY | A | 556 | — | — | 44,011 Direct | +1.28% | Acquired | (price as of 2026-08-19) |
| July 11, 2025 | XRAY | A | 432 | — | — | 43,455 Direct | +1.00% | Acquired | (price as of 2026-08-19) |
| May 30, 2025 | XRAY | A | 173,800 | — | — | 173,800 Direct | — | Acquired | (price as of 2026-08-19) |
| May 30, 2025 | XRAY | A | 43,023 | — | — | 43,023 Direct | — | Acquired | (price as of 2026-08-19) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| May 30, 2025 | XRAY | Stock Option (Right to Buy) | Common Stock (173,800) | $15.98 | May 30, 2035 | 173,800 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 3 holdings
Securities held when first becoming an insider, per SEC Form 3.
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
XRAY
CFO| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2025 | $350,685 | — | $2,118,608 | $676,116 | — | — | $648,949 | $3,794,358 |
MTX
CFO| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2022 | $549,228 | — | $567,695 | $338,824 | — | — | $38,809 | $1,494,556 |
| 2021 | $549,814 | — | $518,562 | $259,279 | $977,608 | — | $36,945 | $2,342,208 |
| 2020 | $533,800 | — | $492,747 | $246,368 | $695,520 | — | $36,152 | $2,004,587 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.